{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:56:54Z","timestamp":1794333414750,"version":"4.9.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"FOREUM Foundation for Research in Rheumatology"},{"name":"South Eastern Regional Health Authorities of Norway","award":["2016063"],"award-info":[{"award-number":["2016063"]}]},{"name":"South Eastern Regional Health Authorities of Norway","award":["2013064"],"award-info":[{"award-number":["2013064"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To explore mortality and causes of death among Norwegian patients with RA, PsA and axial spondyloarthritis (axSpA) compared with the general population by conducting a nationwide registry-based cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with RA, PsA and axSpA were identified from the Norwegian Patient Registry based on ICD-10 codes between 2008 and 2017. Using age as the time variable, all-cause and cause-specific mortality were estimated between 2010 and 2017 with the Kaplan\u2013Meier estimator and the cumulative incidence competing risk method, respectively. Sex-, education level-, health region- and age group-adjusted hazard ratios (HRs) for mortality were estimated using Cox regression models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 36\u2009095 RA, 18\u2009700 PsA and 16\u2009524 axSpA patients (70%, 53% and 45% women, respectively). RA and axSpA were associated with increased all-cause mortality (HR 1.45 [95% CI: 1.41, 1.48] and HR 1.38 [95% CI: 1.28, 1.38], respectively). Women but not men with PsA had a slightly increased mortality rate (HR 1.10 [95% CI: 1.00, 1.21] among women and 1.02 [95% CI: 0.93, 1.11] among men). For all patient groups as well as for the general population, the three leading causes of death were cardiovascular diseases, neoplasms and respiratory diseases. RA patients had increased mortality from all of these causes, while axSpA patients had increased mortality from cardiovascular and respiratory diseases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Even in the era of modern treatments for IJDs, patients with RA and axSpA still have shortened life expectancy. Our findings warrant further attention to the prevention and management of comorbidities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac210","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T13:12:32Z","timestamp":1649077952000},"page":"4656-4666","source":"Crossref","is-referenced-by-count":85,"title":["All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-3291","authenticated-orcid":false,"given":"Anne M","family":"Kerola","sequence":"first","affiliation":[{"name":"Preventive Cardio-Rheuma clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway"},{"name":"Department of Internal Medicine, P\u00e4ij\u00e4t-H\u00e4me Joint Authority for Health and Wellbeing , Lahti"},{"name":"Faculty of Medicine, University of Helsinki , Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Kazemi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Research, Diakonhjemmet Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rollefstad","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Lillegraven","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Research, Diakonhjemmet Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sexton","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Research, Diakonhjemmet Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grunde","family":"Wibetoe","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen A","family":"Haavardsholm","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Research, Diakonhjemmet Hospital"},{"name":"Faculty of Medicine, University of Oslo , Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore K","family":"Kvien","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Research, Diakonhjemmet Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-2853","authenticated-orcid":false,"given":"Anne Grete","family":"Semb","sequence":"additional","affiliation":[{"name":"Preventive Cardio-Rheuma clinic, Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"2022112912441609300_keac210-B1","article-title":"Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents","author":"Kerola","journal-title":"Scand J Rheumatol"},{"key":"2022112912441609300_keac210-B2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbspin.2012.02.005","article-title":"Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis","volume":"80","author":"Dadoun","year":"2013","journal-title":"Joint Bone Spine"},{"key":"2022112912441609300_keac210-B3","first-page":"S35","article-title":"Mortality in rheumatoid arthritis: 2008 update","volume":"26","author":"Sokka","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2022112912441609300_keac210-B4","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3899\/jrheum.160070","article-title":"Disease activity and increased risk of cardiovascular death among patients with psoriatic arthritis","volume":"43","author":"Juneblad","year":"2016","journal-title":"J Rheumatol"},{"key":"2022112912441609300_keac210-B5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/kew502","article-title":"Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis","volume":"56","author":"Ogdie","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2022112912441609300_keac210-B6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"key":"2022112912441609300_keac210-B7","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/annrheumdis-2015-207688","article-title":"Mortality in ankylosing spondylitis: results from a nationwide population-based study","volume":"75","author":"Exarchou","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B8","first-page":"430","article-title":"Prediction of mortality in rheumatoid arthritis based on disease activity markers","volume":"32","author":"Book","year":"2005","journal-title":"J Rheumatol"},{"key":"2022112912441609300_keac210-B9","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","article-title":"Increased mortality in ankylosing spondylitis is related to disease activity","volume":"70","author":"Bakland","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1403494819859737","article-title":"The Norwegian patient registry and the Norwegian Registry for Primary Health Care: research potential of two nationwide health-care registries","volume":"48","author":"Bakken","year":"2020","journal-title":"Scand J Public Health"},{"key":"2022112912441609300_keac210-B11","author":"Therneau","year":"2021"},{"key":"2022112912441609300_keac210-B12","first-page":"1","article-title":"mice: Multivariate Imputation by Chained Equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Soft"},{"key":"2022112912441609300_keac210-B13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/annrheumdis-2012-202603","article-title":"Inequities in access to biologic and synthetic DMARDs across 46 European countries","volume":"73","author":"Putrik","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B14","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2016-209562","article-title":"Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population\u2014closing the mortality gap","volume":"76","author":"Lacaille","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/rheumatology\/key013","article-title":"Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink","volume":"57","author":"Abhishek","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2022112912441609300_keac210-B16","first-page":"505","article-title":"Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study","volume":"59","author":"Provan","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2022112912441609300_keac210-B17","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1136\/ard.2009.125492","article-title":"No increased mortality in incident cases of rheumatoid arthritis during the new millennium","volume":"69","author":"Puolakka","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B18","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/annrheumdis-2012-202789","article-title":"Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic","volume":"72","author":"Rollefstad","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B19","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41598-020-60621-2","article-title":"Mortality is increased in patients with rheumatoid arthritis or diabetes compared to the general population \u2013 the Nord-Tr\u00f8ndelag Health Study","volume":"10","author":"Houge","year":"2020","journal-title":"Sci Rep"},{"key":"2022112912441609300_keac210-B20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/annrheumdis-2017-212131","article-title":"Mortality following new-onset rheumatoid arthritis: has modern rheumatology had an impact?","volume":"77","author":"Holmqvist","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/acr.22296","article-title":"Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register","volume":"66","author":"Humphreys","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2022112912441609300_keac210-B22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1756-185X.13970","article-title":"Cardiovascular morbidity and mortality in patients with spondyloarthritis: a meta-analysis","volume":"24","author":"Kim","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2022112912441609300_keac210-B23","doi-asserted-by":"crossref","first-page":"iv47","DOI":"10.1093\/rheumatology\/keaa246","article-title":"Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis","volume":"59","author":"Zhao","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2022112912441609300_keac210-B24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/annrheumdis-2013-204021","article-title":"Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNF\u03b1 inhibitors and rituximab","volume":"74","author":"Listing","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.semarthrit.2020.04.001","article-title":"Mortality in psoriatic arthritis: risk, causes of death, predictors for death","volume":"50","author":"Elalouf","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2022112912441609300_keac210-B26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.16919","article-title":"Cause-specific mortality in patients with psoriasis and psoriatic arthritis","volume":"180","author":"Skov","year":"2019","journal-title":"Br J Dermatol"},{"key":"2022112912441609300_keac210-B27","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3899\/jrheum.100034","article-title":"Mortality in psoriatic arthritis \u2013 a single-center study from the UK","volume":"37","author":"Buckley","year":"2010","journal-title":"J Rheumatol"},{"key":"2022112912441609300_keac210-B28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/rheumatology\/key241","article-title":"Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register","volume":"58","author":"Fagerli","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2022112912441609300_keac210-B29","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.15420\/ecr.2020.44","article-title":"Atherosclerotic cardiovascular disease in rheumatoid arthritis: impact of inflammation and antirheumatic treatment","volume":"16","author":"Kerola","year":"2021","journal-title":"Eur Cardiol"},{"key":"2022112912441609300_keac210-B30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","article-title":"Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?","volume":"76","author":"Eriksson","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B32","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","article-title":"Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies","volume":"48","author":"Meune","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2022112912441609300_keac210-B33","first-page":"391","article-title":"No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008","volume":"33","author":"Kerola","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2022112912441609300_keac210-B34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3899\/jrheum.161154","article-title":"Decreased cardiovascular mortality in patients with incident rheumatoid arthritis (RA) in recent years: dawn of a new era in cardiovascular disease in RA?","volume":"44","author":"Myasoedova","year":"2017","journal-title":"J Rheumatol"},{"key":"2022112912441609300_keac210-B35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","article-title":"Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review","volume":"72","author":"Jamnitski","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022112912441609300_keac210-B36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/03009742.2019.1672783","article-title":"Cardiovascular risk factors are highly overrepresented in Swedish patients with psoriatic arthritis compared with the general population","volume":"49","author":"Landgren","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"2022112912441609300_keac210-B37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1445-5994.2012.02727.x","article-title":"How many life years are lost in patients with rheumatoid arthritis? Secular cause-specific and all-cause mortality in rheumatoid arthritis, and their predictors in a long-term Australian cohort study","volume":"43","author":"Lassere","year":"2013","journal-title":"Intern Med J"},{"key":"2022112912441609300_keac210-B38","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/acr.23548","article-title":"Causes of death in rheumatoid arthritis: how do they compare to the general population?","volume":"70","author":"Widdifield","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2022112912441609300_keac210-B39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2022112912441609300_keac210-B40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1756-185X.14036","article-title":"Cancer diagnosis and mortality in patients with ankylosing spondylitis: a Western Australian retrospective cohort study","volume":"24","author":"Kelty","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2022112912441609300_keac210-B41","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/rheumatology\/keaa577","article-title":"Rheumatoid arthritis related interstitial lung disease \u2013 improving outcomes over 25 years: a large multicentre UK study","volume":"60","author":"Kelly","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2022112912441609300_keac210-B42","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/rheumatology\/kew344","article-title":"Adverse events of glucocorticoids during treatment of rheumatoid arthritis: lessons from cohort and registry studies","volume":"55","author":"Bijlsma","year":"2016","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac210\/43407476\/keac210.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/12\/4656\/47386089\/keac210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/12\/4656\/47386089\/keac210.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T12:47:57Z","timestamp":1669726077000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/12\/4656\/6563184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,4,4]]},"published-print":{"date-parts":[[2022,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac210","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,4,4]]}}}